By Fineline Cube 
France major Sanofi (NASDAQ: SNY) this week signed a Memorandum of Understanding (MoU) with the Department of Health – Abu Dhabi (DoH). The partnership aims to leverage the UAE’s health technology ecosystem and advanced research infrastructure to accelerate the development of new global vaccines and enhance regional vaccine manufacturing capabilities.
Collaboration Objectives
The partnership seeks to shorten the timeline from early-stage research to widespread vaccine application. This will be achieved by utilizing cutting-edge technologies, real-time data analysis, and parallel clinical trial phases.
Methodology
Both parties will work together to streamline regulatory processes, strengthen production readiness, and foster knowledge-sharing between local and international experts. The collaboration will advance clinical research and development planning, optimize resource allocation, and establish key terms for funding and accessibility.-Fineline Info & Tech